These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 24867389

  • 21. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.
    Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJA, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, Tortora G, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N, Wood LD.
    Nat Genet; 2013 Dec; 45(12):1470-1473. PubMed ID: 24185509
    [Abstract] [Full Text] [Related]

  • 22. Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma.
    Xu S, Guo Y, Zeng Y, Song Z, Zhu X, Fan N, Zhang Z, Ren G, Zang Y, Rao W.
    BMC Cancer; 2021 Feb 12; 21(1):152. PubMed ID: 33579226
    [Abstract] [Full Text] [Related]

  • 23. Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.
    Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR.
    Hum Pathol; 2013 Jul 12; 44(7):1216-22. PubMed ID: 23391413
    [Abstract] [Full Text] [Related]

  • 24. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K, Fukumoto T, Ajiki T, Otani K, Kanzawa M, Akita M, Kido M, Ku Y, Itoh T, Zen Y.
    Histopathology; 2016 Dec 12; 69(6):950-961. PubMed ID: 27410028
    [Abstract] [Full Text] [Related]

  • 25. Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures.
    Mody K, Jain P, El-Refai SM, Azad NS, Zabransky DJ, Baretti M, Shroff RT, Kelley RK, El-Khouiery AB, Hockenberry AJ, Lau D, Lesinski GB, Yarchoan M.
    JCO Precis Oncol; 2022 Jun 12; 6():e2100510. PubMed ID: 35675577
    [Abstract] [Full Text] [Related]

  • 26. Mutation spectrum associated with metastasis of advanced cholangiocarcinoma.
    Song H, Huang Y, Jiang X.
    J Int Med Res; 2022 Jun 12; 50(6):3000605221102080. PubMed ID: 35726602
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma.
    Deshpande V, Nduaguba A, Zimmerman SM, Kehoe SM, Macconaill LE, Lauwers GY, Ferrone C, Bardeesy N, Zhu AX, Hezel AF.
    BMC Cancer; 2011 Feb 08; 11():60. PubMed ID: 21303542
    [Abstract] [Full Text] [Related]

  • 29. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
    Schlitter AM, Born D, Bettstetter M, Specht K, Kim-Fuchs C, Riener MO, Jeliazkova P, Sipos B, Siveke JT, Terris B, Zen Y, Schuster T, Höfler H, Perren A, Klöppel G, Esposito I.
    Mod Pathol; 2014 Jan 08; 27(1):73-86. PubMed ID: 23828315
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.
    Goeppert B, Frauenschuh L, Renner M, Roessler S, Stenzinger A, Klauschen F, Warth A, Vogel MN, Mehrabi A, Hafezi M, Boehmer K, von Deimling A, Schirmacher P, Weichert W, Capper D.
    Mod Pathol; 2014 Jul 08; 27(7):1028-34. PubMed ID: 24309328
    [Abstract] [Full Text] [Related]

  • 32. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W, Zhang J, Zhan X, Lin T, Yang M, Hu J, Han B, Hu S.
    Biochem Biophys Res Commun; 2014 Sep 26; 452(3):614-21. PubMed ID: 25181339
    [Abstract] [Full Text] [Related]

  • 33. Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.
    Misumi K, Hayashi A, Shibahara J, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M.
    Histopathology; 2017 Apr 26; 70(5):766-774. PubMed ID: 27864835
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas.
    Gwak GY, Yoon JH, Shin CM, Ahn YJ, Chung JK, Kim YA, Kim TY, Lee HS.
    J Cancer Res Clin Oncol; 2005 Oct 26; 131(10):649-52. PubMed ID: 16032426
    [Abstract] [Full Text] [Related]

  • 36. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
    Akita M, Fujikura K, Ajiki T, Fukumoto T, Otani K, Azuma T, Itoh T, Ku Y, Zen Y.
    Mod Pathol; 2017 Jul 26; 30(7):986-997. PubMed ID: 28338651
    [Abstract] [Full Text] [Related]

  • 37. Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type Lesions.
    Masetto F, Mafficini A, Saka B, Armutlu A, Chatterjee D, Jang KT, Zen Y, Navale P, Fassan M, Bacchi CE, Mattiolo P, Simbolo M, Ruzzenente A, Lawlor RT, Reid M, Basturk O, Adsay V, Scarpa A, Luchini C.
    Am J Surg Pathol; 2024 Sep 01; 48(9):1082-1092. PubMed ID: 38946053
    [Abstract] [Full Text] [Related]

  • 38. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R, Li Q, Fu J, Jin Z, Su J, Zhang J, Chen C, Geng Z, Zhang D.
    BMC Cancer; 2021 Feb 03; 21(1):112. PubMed ID: 33535978
    [Abstract] [Full Text] [Related]

  • 39. A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier.
    Song Y, Boerner T, Drill E, Shin P, Kumar S, Sigel C, Cercek A, Kemeny N, Abou-Alfa G, Iacobuzio-Donahue C, Cowzer D, Schultz N, Walch H, Balachandran V, Groot Koerkamp B, Kingham P, Soares K, Wei A, D'Angelica M, Drebin J, Chandwani R, Harding JJ, Jarnagin W.
    Clin Cancer Res; 2024 Aug 15; 30(16):3499-3511. PubMed ID: 38864854
    [Abstract] [Full Text] [Related]

  • 40. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
    Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, Carpino G.
    Liver Int; 2019 May 15; 39 Suppl 1():7-18. PubMed ID: 30882996
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.